Home Healthcare Medical Devices Respiratory Care Devices Market

Respiratory Care Devices Market Size, Share & Trends Analysis Report By Product (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables and Accessories), By Application (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, Others), By End-User (Hospitals, Specialty Clinics, Home Care, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:

Respiratory Care Devices Market Size & Growth Analysis

The global respiratory care devices market size was valued at USD 26.4 billion in 2025 and is projected to grow from USD 28.03 billion in 2026 to USD 45.29 billion by 2034, registering a CAGR of 6.18% during the forecast period from 2026 to 2034. North America dominated the respiratory care devices market with a market share of 45.72% in 2025.

The global respiratory care devices market encompasses a wide range of products and technologies designed to support, monitor, and enhance respiratory function in patients across diverse healthcare settings. The market includes therapeutic devices such as positive airway pressure devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, capnographs, gas analyzers, and oxygen hoods, which are essential for efficient respiratory therapy and oxygen management.

Monitoring devices include various pulse oximeters such as pediatric, wrist-worn, hand-held, fingertip, and table-top models, used to continuously assess oxygen saturation and respiratory performance, while diagnostic devices such as spirometers, polysomnography systems, and peak flow meters enable precise evaluation of lung capacity, airflow, and sleep-related breathing disorders. Additionally, consumables and accessories, including disposable masks, nasal cannulas, and other related products, play a vital role in ensuring hygiene, comfort, and infection control during respiratory care. These devices are widely used for applications such as chronic obstructive pulmonary disease, sleep apnea, asthma, infectious diseases, and other respiratory conditions. They are utilized across hospitals, specialty clinics, home care settings, and other healthcare facilities, each adopting specific technologies and treatment approaches according to patient requirements, disease severity, and care delivery models.

Market Key Takeaways

Global Market Size & Growth

North America held a dominant share of the global market, accounting for 45.72% share in 2025.
The Asia Pacific region is growing at the fastest pace, with a CAGR of 7.12%.
Based on Product, the therapeutic devices segment dominated the market in 2025 with a revenue share of 59.42%.
Based on the Application, the sleep apnea segment is expected to register the fastest CAGR growth of 8.12%.
Based on End User, the hospitals segment dominated the market in 2025, with a revenue share of 35.23%.
The U.S. dominates the global respiratory care devices market, valued at USD 10.77 billion in 2024 and reaching USD 11.38 billion in 2025.
2025 Market Size
USD 26.40 billion
2034 Projected Market Size
USD 45.13 billion
CAGR (2025 to 2034)
6.18%
Dominating Region
North America
Fastest-Growing Region
Asia Pacific
Respiratory Care Devices Market Size

Download a Free Sample To learn more about this report.

Product Insights

The therapeutic devices segment dominated the market in 2025 with a revenue share of 59.42%. The growth is attributed to the rising demand for advanced treatment options, hospitals and clinics investing in therapeutic equipment, and technological advancements in ventilators, nebulizers, and oxygen therapy devices.

The monitoring devices are anticipated to register the fastest CAGR of 7.12% during the forecast period, owing to the rising adoption of wearable and compact pulse oximeters for pediatric and geriatric patients, the increasing use of remote monitoring platforms in home care settings, and the integration of AI-driven analytics for early detection of respiratory complications.

Respiratory Care Devices Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

The sleep apnea devices segment is anticipated to grow at a CAGR of 8.12% from 2026 - 2034. This growth is attributed to the rising prevalence of sleep apnea, increasing awareness about sleep disorders, growing adoption of home-based BiPAP devices, technological advancements in wearable and connected devices, and supportive insurance coverage.

The chronic obstructive pulmonary disease (COPD) segment dominates the market, with a revenue share of 37.82%, owing to the increasing geriatric population globally, which is more susceptible to chronic respiratory disorders, and the rising adoption of long-term oxygen therapy for COPD management.

End-User Insights

The hospitals segment dominated the market in 2025, with a revenue share of 35.23%. The growth is attributed to the high demand for advanced respiratory care treatments, increasing hospital admissions for chronic and acute respiratory diseases, the availability of specialized respiratory equipment, and hospitals’ capacity to invest in advanced devices.

The home care segment is estimated to register the fastest CAGR of 8.35% during the forecast period, owing to the growing demand for portable and compact respiratory devices that allow patients to manage chronic conditions, and the rising preference for non-hospital-based care among elderly and post-COVID-19 patients.

Respiratory Care Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

The North America region dominated the market with a revenue share of 45.72% in 2025. The growth is attributed to factors such as well-established healthcare infrastructure, advanced technology adoption in medical devices, and government initiatives supporting respiratory care programs.

The respiratory care devices market in the U.S. is widely driven by the recent CMS National Coverage Determination (NCD) for home non-invasive positive pressure ventilation (NIPPV) in patients with chronic respiratory failure due to COPD. This policy expands coverage for respiratory assist devices (RADs) and home mechanical ventilators under specific clinical criteria. By increasing reimbursement access, this factor directly boosts the market size and stimulates the respiratory care devices market growth as more patients qualify for home ventilatory support.

North America Respiratory Care Devices Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

The Asia Pacific region is the fastest-growing region with a CAGR of 7.12% during the forecast timeframe. The growth is attributed to factors such as increasing awareness of respiratory care, and rising demand for home-based respiratory care devices.

India continues to position itself in the respiratory care devices market, due to the government's strategic initiatives, particularly the National Medical Devices Policy 2023. This policy aims to position India as a global hub for medical device manufacturing, offering incentives, such as the Production Linked Incentive (PLI) scheme, and establishing medical device parks. Such measures enhance domestic production capabilities, reduce import dependency, and make respiratory care devices more accessible and affordable.

Europe Market Insights

The European respiratory care devices market is witnessing growth due to the increasing integration of environmentally sustainable and energy-efficient respiratory devices driven by regional regulations and hospital sustainability initiatives. Hospitals and clinics are increasingly adopting low-power ventilators, reusable resuscitators, and eco-friendly consumables to reduce carbon footprint while maintaining high-quality patient care. This focus on green healthcare technologies, combined with incentives for eco-conscious medical equipment procurement and rising patient demand for devices that are both efficient and environmentally responsible, is creating a unique growth driver for the European respiratory care devices market.

The respiratory care devices market in UK is propelling due to the expansion of home mechanical ventilation (HMV) services commissioning, under NHS England’s “Complex Home Mechanical Ventilation” Model of Care. This guidance requires Integrated Care Boards (ICBs) to fund home ventilators, MI-E devices, suction machines and nebulisers, boosting market size by increasing device prescriptions. This element makes respiratory care devices market growth stronger because more patients can access these equipment at home.

Middle East and Africa Market Insights

The Middle East and Africa respiratory care devices market is experiencing growth due to the expansion of mobile and temporary healthcare facilities in remote and underserved regions, which rely heavily on portable respiratory devices such as compact oxygen concentrators, mobile ventilators, and handheld pulse oximeters. Frequent outbreaks of respiratory infections and environmental challenges like high dust and pollution levels have increased the demand for on-the-go therapeutic and monitoring solutions.

The South African respiratory care devices market is growing due to the rising demand for cold-chain compatible and battery-operated respiratory devices in remote and off-grid areas, where consistent electricity supply is limited. This has driven the adoption of portable oxygen concentrators, battery-powered nebulizers, and solar-assisted ventilators that can function efficiently in rural clinics and mobile healthcare units.

Latin America Market Insights

The Latin American respiratory care devices market is witnessing growth due to the increased prevalence of environmental and climate-related respiratory challenges, such as frequent wildfires, and seasonal dust storms. These factors have driven demand for portable air filtration devices, inhalers, nebulizers, and monitoring tools that support managing acute respiratory episodes and preventing complications.

The Argentina respiratory care devices market is witnessing growth due to the increasing adoption of digital health platforms for remote respiratory monitoring and patient education. Hospitals, specialty clinics, and home care providers are leveraging connected devices such as smart pulse oximeters, wireless spirometers, and app-integrated PAP systems to track patient progress, adjust therapies, and improve adherence.

Competitive Landscape

The global Respiratory Care Devices (IVF) market is highly fragmented with the presence of numerous multinational corporations such as Koninklijke Philips N.V., Medtronic, 3M, ResMed and Others.

The industry participants are inclined towards developing technologically advanced, portable, and cost-effective respiratory care devices to address rising demand across critical care, emergency, and home care settings, which further enhances the growth of respiratory care devices.

CorVent Medical Inc: An emerging market player

CorVent Medical Inc. is an emerging player in the respiratory care devices market, focused on advanced ventilator solutions.

  • In November 2024, CorVent Medical received U.S. FDA 510(k) clearance for its RESPOND Ventilator, a next-generation critical care system designed to provide versatile, cost-effective respiratory support for hospitals facing capacity challenges.

List of Key and Emerging Players in Respiratory Care Devices Market

Koninklijke Philips N.V.
3M
Medtronic
Resmed
Masimo
Fisher & Paykel Healthcare Limited
Getinge
Drägerwerk AG & Co. KGaA
Nihon Kohden Corporation
GE HealthCare
Vyaire
Air Liquide Medical Systems
ICU Medical, Inc.
OMRON Healthcare Co., Ltd.
Teleflex Incorporated
Pulmodyne, Inc.
Drive Devilbiss International
Breas Medical AB
GE HealthCare
Others

Key Industry Developments

March 2026
Philips expanded its respiratory care portfolio with advanced ventilators, oxygen therapy systems, and sleep therapy solutions designed to improve respiratory disease management in hospitals and home healthcare settings.
January 2026
ResMed expanded its respiratory care solutions portfolio with enhanced CPAP, bilevel therapy, and digital health technologies designed to improve sleep apnea management and remote patient monitoring.
October 2025
Medtronic expanded its respiratory and ventilation solutions portfolio with advanced mechanical ventilation technologies designed for critical care environments and improved patient outcomes.
August 2025
Fisher & Paykel Healthcare expanded its respiratory care product portfolio with upgraded airway management, humidification, and breathing system solutions for hospital and home care applications.

Report Scope

Segmentation

By Product 4
  • Therapeutic Devices
  • Monitoring Devices
  • Diagnostic Devices
  • Consumables and Accessories
By Application 5
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Sleep Apnea
  • Asthma
  • Infectious Diseases
  • Others
By End-User 4
  • Hospitals
  • Specialty Clinics
  • Home Care
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Koninklijke Philips N.V. · 3M · Medtronic · Resmed · Masimo
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The respiratory care devices market size is valued at USD 28.03 Billion in 2026 and is projected to reach USD 45.29 Billion by 2034, at a CAGR of 6.18% during the forecast period 2026-2034.

North America dominated the market with a share of 45.72% in 2025.

The leading players in this market are Koninklijke Philips N.V., 3M, Medtronic, Resmed, Masimo.

The respiratory care devices market is projected to grow at a CAGR of 6.18% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: